297 related articles for article (PubMed ID: 16672248)
1. Engineering stability into Escherichia coli secreted Fabs leads to increased functional expression.
Demarest SJ; Chen G; Kimmel BE; Gustafson D; Wu J; Salbato J; Poland J; Elia M; Tan X; Wong K; Short J; Hansen G
Protein Eng Des Sel; 2006 Jul; 19(7):325-36. PubMed ID: 16672248
[TBL] [Abstract][Full Text] [Related]
2. High level production of functional antibody Fab fragments in an oxidizing bacterial cytoplasm.
Venturi M; Seifert C; Hunte C
J Mol Biol; 2002 Jan; 315(1):1-8. PubMed ID: 11771962
[TBL] [Abstract][Full Text] [Related]
3. Differences in sequence-specific expression of two anti-arsonate Fabs in E. coli.
Gill DS; Wong YW; Margolies MN
Biotechnol Prog; 1997; 13(5):692-4. PubMed ID: 9336990
[TBL] [Abstract][Full Text] [Related]
4. An optimized procedure for efficient phage display of antibody fragments with a low folding efficiency.
Kuba H; Furukawa K
Protein Expr Purif; 2009 Jun; 65(2):148-53. PubMed ID: 19297692
[TBL] [Abstract][Full Text] [Related]
5. Efficient bacterial production of functional antibody fragments using a phagemid vector.
Kuba H; Furukawa A; Okajima T; Furukawa K
Protein Expr Purif; 2008 Apr; 58(2):292-300. PubMed ID: 18077183
[TBL] [Abstract][Full Text] [Related]
6. Structure-based stability engineering of the mouse IgG1 Fab fragment by modifying constant domains.
Teerinen T; Valjakka J; Rouvinen J; Takkinen K
J Mol Biol; 2006 Aug; 361(4):687-97. PubMed ID: 16876195
[TBL] [Abstract][Full Text] [Related]
7. Helix-stabilized Fv (hsFv) antibody fragments: substituting the constant domains of a Fab fragment for a heterodimeric coiled-coil domain.
Arndt KM; Müller KM; Plückthun A
J Mol Biol; 2001 Sep; 312(1):221-8. PubMed ID: 11545598
[TBL] [Abstract][Full Text] [Related]
8. Properties of FV and Fab fragments of the antibody McPC603 expressed in E. coli.
Plückthun A; Glockshuber R; Skerra A; Stadmüller J
Behring Inst Mitt; 1990 Dec; (87):48-55. PubMed ID: 2096820
[TBL] [Abstract][Full Text] [Related]
9. Functional humanization of an anti-CD16 Fab fragment: obstacles of switching from murine {lambda} to human {lambda} or {kappa} light chains.
Schlapschy M; Fogarasi M; Gruber H; Gresch O; Schäfer C; Aguib Y; Skerra A
Protein Eng Des Sel; 2009 Mar; 22(3):175-88. PubMed ID: 19022801
[TBL] [Abstract][Full Text] [Related]
10. Bacterial production and functional characterization of the Fab fragment of the murine IgG1/lambda monoclonal antibody cmHsp70.1, a reagent for tumour diagnostics.
Friedrich L; Stangl S; Hahne H; Küster B; Köhler P; Multhoff G; Skerra A
Protein Eng Des Sel; 2010 Apr; 23(4):161-8. PubMed ID: 20123884
[TBL] [Abstract][Full Text] [Related]
11. Engineering antibodies for stability and efficient folding.
Honegger A
Handb Exp Pharmacol; 2008; (181):47-68. PubMed ID: 18071941
[TBL] [Abstract][Full Text] [Related]
12. Domain interactions in the Fab fragment: a comparative evaluation of the single-chain Fv and Fab format engineered with variable domains of different stability.
Röthlisberger D; Honegger A; Plückthun A
J Mol Biol; 2005 Apr; 347(4):773-89. PubMed ID: 15769469
[TBL] [Abstract][Full Text] [Related]
13. Functional expression and display of an antibody Fab fragment in Escherichia coli: study of vector designs and culture conditions.
Corisdeo S; Wang B
Protein Expr Purif; 2004 Apr; 34(2):270-9. PubMed ID: 15003261
[TBL] [Abstract][Full Text] [Related]
14. Improvements in the cell-free production of functional antibodies using cell extract from protease-deficient Escherichia coli mutant.
Ali M; Suzuki H; Fukuba T; Jiang X; Nakano H; Yamane T
J Biosci Bioeng; 2005 Feb; 99(2):181-6. PubMed ID: 16233776
[TBL] [Abstract][Full Text] [Related]
15. Bacterial expression and purification of recombinant bovine Fab fragments.
O'Brien PM; Maxwell G; Campo MS
Protein Expr Purif; 2002 Feb; 24(1):43-50. PubMed ID: 11812221
[TBL] [Abstract][Full Text] [Related]
16. Temperature-induced expression of human-mouse chimeric Fab.
Zan H; Yeh M
Chin J Biotechnol; 1997; 13(2):63-70. PubMed ID: 9343703
[TBL] [Abstract][Full Text] [Related]
17. Automated high-throughput purification of antibody fragments to facilitate evaluation in functional and kinetic based assays.
Su B; Hrin R; Harvey BR; Wang YJ; Ernst RE; Hampton RA; Miller MD; Strohl WR; An Z; Montgomery DL
J Immunol Methods; 2007 Apr; 322(1-2):94-103. PubMed ID: 17362979
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human antibodies: linkage of an Fab fragment from a combinatorial library to an Fc fragment for expression in mammalian cell culture.
Bender E; Woof JM; Atkin JD; Barker MD; Bebbington CR; Burton DR
Hum Antibodies Hybridomas; 1993 Apr; 4(2):74-9. PubMed ID: 8518367
[TBL] [Abstract][Full Text] [Related]
19. Selection for improved protein stability by phage display.
Jung S; Honegger A; Plückthun A
J Mol Biol; 1999 Nov; 294(1):163-80. PubMed ID: 10556036
[TBL] [Abstract][Full Text] [Related]
20. Transfer of engineered biophysical properties between different antibody formats and expression systems.
Schaefer JV; Plückthun A
Protein Eng Des Sel; 2012 Oct; 25(10):485-506. PubMed ID: 22763265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
